BSECompany Update23 Jun 2026 · 23 Jun 2026, 06:12 pm
Disclosure under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 - Intimation of Institutional Investor Meeting - Plant Visit
Alivus Life Sciences Ltd · 543322
✦ AI Summary
Alivus Life Sciences Ltd (formerly Glenmark Life Sciences Limited) has announced an institutional investor meeting in the form of a plant visit scheduled for June 29, 2026, at its Ankleshwar, Gujarat facility. This visit, which may be a group or one-on-one meeting, is to facilitate engagement with institutional investors. The company noted that the schedule and mode could change due to exigencies.
Analysis Scores
Earnings Impact2/10
Growth Catalyst5/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment6/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Alivus Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Attachments (1)
📄pdf
Download →
0e14d9e0-1c63-4e88-b64a-30f55ccf8537.pdf
View document text
June 23, 2026
To, To,
Dy. General Manager The Manager – Listing,
Department of Corporate Services, National Stock Exchange of India Ltd.,
BSE Ltd., Plot No. C/1, G Block,
P. J. Towers, Dalal Street, Bandra Kurla Complex,
Fort, Mumbai – 400 001 Bandra (E), Mumbai – 400 051
Ref: Scrip Code: 543322 Ref: Scrip Name: ALIVUS
Dear Sirs,
Sub: Disclosure under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements)
Regulations, 2015 – Intimation of Institutional Investor Meeting – Plant Visit
With reference to the captioned subject and pursuant to Regulation 30 and Para A of Part A of
Schedule III of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, we would
like to inform that few Institutional Investors will be visiting the Company’s Plant as follows:
Date Particulars Mode Place Type of Meeting
June 29, 2026 Plant Visit for In-Person Ankleshwar, Gujarat Group/One on One
Institutional Investors
The schedule and mode of meeting may undergo a change due to exigencies on part of the
Investor/Company.
You are requested to kindly take a note of the same.
Thanking You,
Yours Sincerely,
For Alivus Life Sciences Limited
(formerly Glenmark Life Sciences Limited)
Rudalf Corriea
Company Secretary & Compliance Officer
Alivus Life Sciences Limited (formerly Glenmark Life Sciences Limited)
Corporate Office: Registered Office:
Technopolis Knowledge Park, A wingO, ffice No. 401 to 407, Plot No 170-172, Chandramouli Industrial Estate
4th Floor, Mahakali Caves Road, Andheri E(), Mumbai– 400093 Mohol Bazarpeth, Solapur 413 213, India
T: +91 22 6829 7979 | CIN: L74900PN2011PLC139963 | E: complianceofficer@alivus.com | W: www.alivus.com